{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T21:12:01Z","timestamp":1768770721300,"version":"3.49.0"},"reference-count":77,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2017,8,17]],"date-time":"2017-08-17T00:00:00Z","timestamp":1502928000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI111967"],"award-info":[{"award-number":["R01AI111967"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1066499"],"award-info":[{"award-number":["OPP1066499"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01HL131072"],"award-info":[{"award-number":["U01HL131072"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL110811"],"award-info":[{"award-number":["R01HL110811"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006132","name":"Office of Science","doi-asserted-by":"publisher","award":["DE-AC02-05CH11231"],"award-info":[{"award-number":["DE-AC02-05CH11231"]}],"id":[{"id":"10.13039\/100006132","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation (US)","doi-asserted-by":"crossref","award":["MCB140228"],"award-info":[{"award-number":["MCB140228"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"DOI":"10.1371\/journal.pcbi.1005650","type":"journal-article","created":{"date-parts":[[2017,8,17]],"date-time":"2017-08-17T17:39:59Z","timestamp":1502991599000},"page":"e1005650","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":68,"title":["Comparing efficacies of moxifloxacin, levofloxacin and gatifloxacin in tuberculosis granulomas using a multi-scale systems pharmacology approach"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5408-8795","authenticated-orcid":true,"given":"Elsje","family":"Pienaar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jansy","family":"Sarathy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brendan","family":"Prideaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jillian","family":"Dietzold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00e9ronique","family":"Dartois","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1053-2591","authenticated-orcid":true,"given":"Denise E.","family":"Kirschner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer J.","family":"Linderman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,8,17]]},"reference":[{"key":"ref1","unstructured":"WHO, Global tuberculosis report. 2015."},{"issue":"10","key":"ref2","doi-asserted-by":"crossref","first-page":"4631","DOI":"10.1128\/IAI.00592-09","article-title":"Quantitative comparison of active and latent tuberculosis in the cynomolgus macaque model","volume":"77","author":"P.L. Lin","year":"2009","journal-title":"Infect Immun"},{"issue":"5","key":"ref3","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nri3211","article-title":"Revisiting the role of the granuloma in tuberculosis","volume":"12","author":"L. Ramakrishnan","year":"2012","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/imr.12252","article-title":"Heterogeneity in tuberculosis pathology, microenvironments and therapeutic responses","volume":"264","author":"A. Lenaerts","year":"2015","journal-title":"Immunol Rev"},{"key":"ref5","article-title":"<italic>WHO treatment guidelines for drug-resistant tuberculosis<\/italic>","year":"2016"},{"key":"ref6","article-title":"<italic>Policy Brief No<\/italic>. <italic>1<\/italic>. 2015, Harvard MEdical School Center for Global Health Delivery-Dubai","author":"J.A. Seddon"},{"key":"ref7","article-title":"Preventing the spread of multidrug-resistant tuberculosis and protecting contacts of infectious cases","author":"G.J. Fox","year":"2016","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"ref8","first-page":"605","article-title":"Early and extended early bactericidal activity of levofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis","volume":"10","author":"J.L. Johnson","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"issue":"3","key":"ref9","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1128\/AAC.01036-07","article-title":"Population pharmacokinetics of levofloxacin, gatifloxacin, and moxifloxacin in adults with pulmonary tuberculosis","volume":"52","author":"C.A. Peloquin","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"ref10","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1378\/chest.125.3.965","article-title":"Steady-state intrapulmonary concentrations of moxifloxacin, levofloxacin, and azithromycin in older adults","volume":"125","author":"B. Capitano","year":"2004","journal-title":"Chest"},{"issue":"2","key":"ref11","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/jac\/dkg343","article-title":"Comparative antimicrobial activities of gatifloxacin, sitafloxacin and levofloxacin against Mycobacterium tuberculosis replicating within Mono Mac 6 human macrophage and A-549 type II alveolar cell lines","volume":"52","author":"K. Sato","year":"2003","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"ref12","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.carres.2010.01.016","article-title":"Synthesis and antitubercular evaluation of new fluoroquinolone derivatives coupled with carbohydrates","volume":"345","author":"M.F. Saraiva","year":"2010","journal-title":"Carbohydr Res"},{"issue":"10","key":"ref13","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1093\/jac\/dkr281","article-title":"Comparison of the bactericidal activity of various fluoroquinolones against Mycobacterium tuberculosis in an in vitro experimental model","volume":"66","author":"R. Cremades","year":"2011","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"ref14","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/jac\/dkh119","article-title":"Mutant prevention concentration: comparison of fluoroquinolones and linezolid with Mycobacterium tuberculosis","volume":"53","author":"J.C. Rodriguez","year":"2004","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"ref15","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1164\/rccm.201303-0604OC","article-title":"Comparison of levofloxacin versus moxifloxacin for multidrug-resistant tuberculosis","volume":"188","author":"W.J. Koh","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ijantimicag.2013.02.019","article-title":"Comparative roles of moxifloxacin and levofloxacin in the treatment of pulmonary multidrug-resistant tuberculosis: a retrospective study","volume":"42","author":"R.H. Jiang","year":"2013","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"ref17","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3904\/kjim.2011.26.2.153","article-title":"Retrospective comparison of levofloxacin and moxifloxacin on multidrug-resistant tuberculosis treatment outcomes","volume":"26","author":"J. Lee","year":"2011","journal-title":"Korean J Intern Med"},{"issue":"2","key":"ref18","first-page":"128","article-title":"A Phase II study of the sterilising activities of ofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis","volume":"12","author":"R. Rustomjee","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"issue":"3","key":"ref19","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nrmicro3200","article-title":"The path of anti-tuberculosis drugs: from blood to lesions to mycobacterial cells","volume":"12","author":"V. Dartois","year":"2014","journal-title":"Nat Rev Microbiol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jtbi.2014.11.021","article-title":"A computational tool integrating host immunity with antibiotic dynamics to study tuberculosis treatment","volume":"367","author":"E. Pienaar","year":"2015","journal-title":"J Theor Biol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12918-015-0221-8","article-title":"In silico evaluation and exploration of antibiotic tuberculosis treatment regimens","volume":"9","author":"E. Pienaar","year":"2015","journal-title":"BMC Syst Biol"},{"key":"ref22","first-page":"e22","article-title":"Systems Pharmacology Approach Toward the Design of Inhaled Formulations of Rifampicin and Isoniazid for Treatment of Tuberculosis","volume":"4","author":"N.A. Cilfone","year":"2015","journal-title":"CPT: Pharmacometrics & Systems Pharmacology"},{"issue":"7","key":"ref23","doi-asserted-by":"crossref","first-page":"e68680","DOI":"10.1371\/journal.pone.0068680","article-title":"Multi-scale modeling predicts a balance of tumor necrosis factor-alpha and interleukin-10 controls the granuloma environment during Mycobacterium tuberculosis infection","volume":"8","author":"N.A. Cilfone","year":"2013","journal-title":"PloS one"},{"issue":"6","key":"ref24","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.4049\/jimmunol.1003299","article-title":"Multiscale computational modeling reveals a critical role for TNF-alpha receptor 1 dynamics in tuberculosis granuloma formation","volume":"186","author":"M. Fallahi-Sichani","year":"2011","journal-title":"J Immunol"},{"issue":"6","key":"ref25","doi-asserted-by":"crossref","first-page":"3706","DOI":"10.4049\/jimmunol.0802297","article-title":"Synergy between individual TNF-dependent functions determines granuloma performance for controlling Mycobacterium tuberculosis infection","volume":"182","author":"J.C. Ray","year":"2009","journal-title":"J Immunol"},{"issue":"3","key":"ref26","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jtbi.2004.06.031","article-title":"Identifying control mechanisms of granuloma formation during M. tuberculosis infection using an agent-based model","volume":"231","author":"J.L. Segovia-Juarez","year":"2004","journal-title":"J Theor Biol"},{"issue":"3","key":"ref27","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/jac\/dku457","article-title":"Comprehensive physicochemical, pharmacokinetic and activity profiling of anti-TB agents","volume":"70","author":"S.B. Lakshminarayana","year":"2015","journal-title":"J Antimicrob Chemother"},{"issue":"22","key":"ref28","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1056\/NEJMra1413919","article-title":"Treatment of Tuberculosis","volume":"373","author":"C.R. Horsburgh Jr.","year":"2015","journal-title":"N Engl J Med"},{"issue":"12","key":"ref29","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/nri2448","article-title":"Exploring the full spectrum of macrophage activation","volume":"8","author":"D.M. Mosser","year":"2008","journal-title":"Nat Rev Immunol"},{"issue":"12","key":"ref30","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1086\/593174","article-title":"Tumor necrosis factor blockers influence macrophage responses to Mycobacterium tuberculosis","volume":"198","author":"J. Harris","year":"2008","journal-title":"J Infect Dis"},{"issue":"4","key":"ref31","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.4049\/jimmunol.181.4.2651","article-title":"NF-kappa B activation controls phagolysosome fusion-mediated killing of mycobacteria by macrophages","volume":"181","author":"M.G. Gutierrez","year":"2008","journal-title":"J Immunol"},{"issue":"1","key":"ref32","doi-asserted-by":"crossref","first-page":"e1004603","DOI":"10.1371\/journal.ppat.1004603","article-title":"Variability in tuberculosis granuloma T cell responses exists, but a balance of pro- and anti-inflammatory cytokines is associated with sterilization","volume":"11","author":"H.P. Gideon","year":"2015","journal-title":"PLoS Pathog"},{"issue":"1","key":"ref33","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jtbi.2008.04.011","article-title":"A methodology for performing global uncertainty and sensitivity analysis in systems biology","volume":"254","author":"S. Marino","year":"2008","journal-title":"J Theor Biol"},{"issue":"Suppl 1","key":"ref34","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1016\/S1472-9792(08)70038-6","article-title":"The early bactericidal activity of anti-tuberculosis drugs: a literature review","volume":"88","author":"P.R. Donald","year":"2008","journal-title":"Tuberculosis (Edinb)"},{"issue":"4 Pt 1","key":"ref35","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1164\/ajrccm.161.4.9903087","article-title":"Predicting the outcome of therapy for pulmonary tuberculosis","volume":"161","author":"R.S. Wallis","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"ref36","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1378\/chest.09-0903","article-title":"Neutrophils are the predominant infected phagocytic cells in the airways of patients with active pulmonary TB","volume":"137","author":"S.Y. Eum","year":"2010","journal-title":"Chest"},{"issue":"5","key":"ref37","first-page":"CD006591","article-title":"Patient education and counselling for promoting adherence to treatment for tuberculosis","author":"J, M. M'Imunya","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"ref38","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1524-4733.2007.00213.x","article-title":"Medication compliance and persistence: terminology and definitions","volume":"11","author":"J.A. Cramer","year":"2008","journal-title":"Value Health"},{"issue":"1","key":"ref39","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nm.3412","article-title":"Sterilization of granulomas is common in active and latent tuberculosis despite within-host variability in bacterial killing","volume":"20","author":"P.L. Lin","year":"2014","journal-title":"Nat Med"},{"issue":"265","key":"ref40","doi-asserted-by":"crossref","first-page":"265ra166","DOI":"10.1126\/scitranslmed.3009501","article-title":"PET\/CT imaging correlates with treatment outcome in patients with multidrug-resistant tuberculosis","volume":"6","author":"R.Y. Chen","year":"2014","journal-title":"Sci Transl Med"},{"key":"ref41","article-title":"Radiologic responses in cynomolgous macaques for assessing tuberculosis chemotherapy regimens","author":"P.L. Lin","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"ref42","first-page":"1081","article-title":"Who fails to complete tuberculosis treatment? Temporal trends and risk factors for treatment interruption in a community-based directly observed therapy programme in a rural district of South Africa","volume":"3","author":"C. Connolly","year":"1999","journal-title":"Int J Tuberc Lung Dis"},{"issue":"15","key":"ref43","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.4155\/fmc.15.128","article-title":"The anti-tuberculosis agents under development and the challenges ahead","volume":"7","author":"D. Kumar","year":"2015","journal-title":"Future Med Chem"},{"issue":"4","key":"ref44","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1473-3099(13)70328-1","article-title":"New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects","volume":"14","author":"A.I. Zumla","year":"2014","journal-title":"Lancet Infect Dis"},{"issue":"17","key":"ref45","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1056\/NEJMoa1315817","article-title":"A four-month gatifloxacin-containing regimen for treating tuberculosis","volume":"371","author":"C.S. Merle","year":"2014","journal-title":"N Engl J Med"},{"issue":"17","key":"ref46","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa1407426","article-title":"Four-month moxifloxacin-based regimens for drug-sensitive tuberculosis","volume":"371","author":"S.H. Gillespie","year":"2014","journal-title":"N Engl J Med"},{"issue":"17","key":"ref47","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1056\/NEJMoa1314210","article-title":"High-dose rifapentine with moxifloxacin for pulmonary tuberculosis","volume":"371","author":"A. Jindani","year":"2014","journal-title":"N Engl J Med"},{"issue":"12","key":"ref48","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.1128\/AAC.45.12.3482-3486.2001","article-title":"Effectiveness of once-weekly rifapentine and moxifloxacin regimens against Mycobacterium tuberculosis in mice","volume":"45","author":"N. Lounis","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"ref49","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1164\/rccm.200602-280OC","article-title":"Potent twice-weekly rifapentine-containing regimens in murine tuberculosis","volume":"174","author":"I.M. Rosenthal","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"ref50","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1164\/rccm.200310-1380OC","article-title":"Moxifloxacin-containing regimen greatly reduces time to culture conversion in murine tuberculosis","volume":"169","author":"E.L. Nuermberger","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"ref51","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1164\/rccm.200407-885OC","article-title":"Moxifloxacin-containing regimens of reduced duration produce a stable cure in murine tuberculosis","volume":"170","author":"E.L. Nuermberger","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"issue":"9670","key":"ref52","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/S0140-6736(09)60333-0","article-title":"Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial","volume":"373","author":"M.B. Conde","year":"2009","journal-title":"Lancet"},{"issue":"3","key":"ref53","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1164\/rccm.200603-360OC","article-title":"Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosis","volume":"174","author":"W.J. Burman","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"ref54","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1128\/AAC.49.9.3977-3979.2005","article-title":"Emergence of fluoroquinolone resistance in Mycobacterium tuberculosis during continuously dosed moxifloxacin monotherapy in a mouse model","volume":"49","author":"A.S. Ginsburg","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"ref55","doi-asserted-by":"crossref","first-page":"e18327","DOI":"10.1371\/journal.pone.0018327","article-title":"Spontaneous emergence of multiple drug resistance in tuberculosis before and during therapy","volume":"6","author":"C. Colijn","year":"2011","journal-title":"PLoS One"},{"issue":"4","key":"ref56","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/ng1755","article-title":"Functional classification of drugs by properties of their pairwise interactions","volume":"38","author":"P. Yeh","year":"2006","journal-title":"Nat Genet"},{"issue":"1","key":"ref57","doi-asserted-by":"crossref","first-page":"e1002487","DOI":"10.1371\/journal.ppat.1002487","article-title":"Two-drug antimicrobial chemotherapy: a mathematical model and experiments with Mycobacterium marinum","volume":"8","author":"P. Ankomah","year":"2012","journal-title":"PLoS Pathog"},{"issue":"6268","key":"ref58","doi-asserted-by":"crossref","first-page":"aad3292","DOI":"10.1126\/science.aad3292","article-title":"Multidrug evolutionary strategies to reverse antibiotic resistance","volume":"351","author":"M. Baym","year":"2016","journal-title":"Science"},{"issue":"4","key":"ref59","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.3892\/etm.2015.2230","article-title":"Super-compact treatment with a high dose of moxifloxacin in patients with drug-resistant tuberculosis and its resistance mechanisms","volume":"9","author":"Q. Wang","year":"2015","journal-title":"Exp Ther Med"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.addr.2016.05.011","article-title":"Dry powder inhalable formulations for anti-tubercular therapy","volume":"102","author":"T. Parumasivam","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"key":"ref61","article-title":"<italic>Development of New Antituberculosis Drugs<\/italic>","author":"S.H. Gillespie","year":"2006"},{"issue":"10","key":"ref62","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/nm.3937","article-title":"The association between sterilizing activity and drug distribution into tuberculosis lesions","volume":"21","author":"B. Prideaux","year":"2015","journal-title":"Nat Med"},{"issue":"4","key":"ref63","doi-asserted-by":"crossref","first-page":"110016","DOI":"10.1098\/rsob.110016","article-title":"Chronic pulmonary cavitary tuberculosis in rabbits: a failed host immune response","volume":"1","author":"S. Subbian","year":"2011","journal-title":"Open Biol"},{"issue":"6","key":"ref64","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1128\/IAI.01515-07","article-title":"Tuberculous granulomas are hypoxic in guinea pigs, rabbits, and nonhuman primates","volume":"76","author":"L.E. Via","year":"2008","journal-title":"Infect Immun"},{"issue":"10","key":"ref65","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.1002\/jps.21317","article-title":"Validation of a rapid equilibrium dialysis approach for the measurement of plasma protein binding","volume":"97","author":"N.J. Waters","year":"2008","journal-title":"J Pharm Sci"},{"issue":"2","key":"ref66","doi-asserted-by":"crossref","first-page":"664","DOI":"10.4049\/jimmunol.1400734","article-title":"Computational modeling predicts interleukin-10 control of lesion sterilization by balancing early host-immunity-mediated antimicrobial responses with caseation during mycobacterium tuberculosis infection","volume":"194","author":"N.A. Cilfone","year":"2015","journal-title":"J Immunol"},{"issue":"4","key":"ref67","doi-asserted-by":"crossref","first-page":"e1004804","DOI":"10.1371\/journal.pcbi.1004804","article-title":"Computational and Empirical Studies Predict Mycobacterium tuberculosis-Specific T Cells as a Biomarker for Infection Outcome","volume":"12","author":"S. Marino","year":"2016","journal-title":"PLoS Comput Biol"},{"key":"ref68","unstructured":"Rohatgi, A. WebPlotDigitizer. September, 2016]; 3.10:[<ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/arohatgi.info\/WebPlotDigitizer\" xlink:type=\"simple\">http:\/\/arohatgi.info\/WebPlotDigitizer<\/ext-link>."},{"issue":"2","key":"ref69","first-page":"239","article-title":"A comparison of three methods for selecting values of input variables in the analysis of output from a computer code","volume":"21","author":"M.D. McKay","year":"1979","journal-title":"Technometrics"},{"issue":"3","key":"ref70","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/0272-4332.00041","article-title":"Illustration of sampling-based methods for uncertainty and sensitivity analysis","volume":"22","author":"J.C. Helton","year":"2002","journal-title":"Risk Anal"},{"issue":"10","key":"ref71","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1128\/AAC.48.10.3670-3676.2004","article-title":"Pharmacodynamic functions: a multiparameter approach to the design of antibiotic treatment regimens","volume":"48","author":"R.R. Regoes","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"ref72","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nm.1915","article-title":"A replication clock for Mycobacterium tuberculosis","volume":"15","author":"W.P. Gill","year":"2009","journal-title":"Nat Med"},{"issue":"6","key":"ref73","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1128\/IAI.64.6.2062-2069.1996","article-title":"An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence","volume":"64","author":"L.G. Wayne","year":"1996","journal-title":"Infect Immun"},{"issue":"10","key":"ref74","doi-asserted-by":"crossref","first-page":"5831","DOI":"10.1128\/IAI.71.10.5831-5844.2003","article-title":"Experimental Mycobacterium tuberculosis infection of cynomolgus macaques closely resembles the various manifestations of human M. tuberculosis infection","volume":"71","author":"S.V. Capuano 3rd","year":"2003","journal-title":"Infect Immun"},{"issue":"7","key":"ref75","doi-asserted-by":"crossref","first-page":"3790","DOI":"10.1128\/IAI.00064-06","article-title":"Early events in Mycobacterium tuberculosis infection in cynomolgus macaques","volume":"74","author":"P.L. Lin","year":"2006","journal-title":"Infect Immun"},{"issue":"7","key":"ref76","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1093\/cid\/ciw376","article-title":"Official American Thoracic Society\/Centers for Disease Control and Prevention\/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis","volume":"63","author":"P. Nahid","year":"2016","journal-title":"Clin Infect Dis"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1146\/annurev-pharmtox-011711-113247","article-title":"Adherence to medications: insights arising from studies on the unreliable link between prescribed and actual drug dosing histories","volume":"52","author":"T.F. Blaschke","year":"2012","journal-title":"Annu Rev Pharmacol Toxicol"}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pcbi.1005650","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T15:49:22Z","timestamp":1602776962000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1005650"}},"subtitle":[],"editor":[{"given":"Scott L","family":"Diamond","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,8,17]]},"references-count":77,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2017,8,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1005650","relation":{},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,17]]}}}